On February 1, 2023, the FTC announced a proposed $1.5 million settlement with GoodRx Holdings, based on alleged violations of the Federal Trade Commission Act (“FTC Act”) and Health Breach Notification Rule (“HBNR”) for using advertising technologies on its websites and mobile app that resulted in the unauthorized disclosure of consumers’ personal and health information to advertisers and other third parties. On the same day, the U.S. Department of Justice, acting on behalf of the FTC, filed a Complaint and Proposed Stipulated Order detailing the FTC’s allegations and the terms of the proposed settlement.
Blog Editors
Recent Updates
- Inside Colorado’s Senate Bill 26-189: Impacts and Implications for Employers
- Watch: Employment Litigation Is More Than Jessica Giambrone Palmese's Practice—It’s Her Passion.
- Watch: State Pay Transparency Laws in 2026 - Maine and Virginia Join the Ranks - Employment Law This Week
- Watch: Words Matter - How to Draft Arbitration Agreements That Hold Up in Court - Employment Law This Week
- One Nation, One Privacy Law: GOP Introduces Federal Privacy Legislation